Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | EGFR | P00533 | 2/20 | 0.54 |
| ▸ | KDR | P35968 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26887084 | 0.95 | NLRP3 (0.61) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL11443749 | 0.94 | NLRP3 (0.59) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL11399068 | 0.94 | NLRP3 (0.58) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL11393542 | 0.94 | NLRP3 (0.58) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL7563975 | 0.94 | NLRP3 (0.58) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL14144110 | 0.92 | NLRP3 (0.57) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL811637 | 0.90 | NLRP3 (0.56) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL1026416 | 0.89 | LMNA (0.61) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL11085743 | 0.88 | SMN1; SMN2 (0.57) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 | |
| SCHEMBL14399629 | 0.88 | ALDH1A1 (0.70) | NLRP3ALDH1A1LMNAMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105860568-A | Primary treatment process of pallet produced by utilizing waste and old textiles | 广德天运新技术股份有限公司 | 2016-08-17 | — | — | CN | claimed |
| US-8846970-B2 | Metal carbamates formed from tolylenediamines | BASF SE (DE) | 2014-09-30 | — | — | US | claimed |
| US-20130231495-A1 | METAL CARBAMATES FORMED FROM TOLYLENEDIAMINES | BASF SE (DE) | 2013-09-05 | — | — | US | claimed |
| EP-2265573-B1 | METAL CARBAMATES COMPOSED OF TOLYLENEDIAMINES | BASF SE (DE) | 2011-10-12 | — | — | EP | claimed |
| US-20110004012-A1 | METAL CARBAMATES FORMED FROM TOLYLENEDIAMINES | BASF SE (DE) | 2011-01-06 | — | — | US | claimed |
| US-4055629-A | Process for the removal of selenium compounds from urethane solutions | ATLANTIC RICHFIELD COMPANY (US) | 1977-10-25 | — | — | US | claimed |
| US-4038375-A | PROCESS FOR THE RECOVERY OF SELENIUM FROM SELENIUM-CONTAINING URETHANE SOLUTIONS | ATLANTIC RICHFIELD COMPANY (US) | 1977-07-26 | — | — | US | claimed |
| US-3993685-A | Process for the production of urethanes | ATLANTIC RICHFIELD COMPANY (US) | 1976-11-23 | — | — | US | claimed |
| US-3962302-A | Production of isocyanates from esters of carbamic acids (urethanes) | ATLANTIC RICHFIELD COMPANY (US) | 1976-06-08 | — | — | US | claimed |
| JP-5201953-A | — | — | None | — | — | JP | disclosed |
| EP-3293173-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2021-07-28 | — | — | EP | disclosed |
| EP-3838892-A1 | METHOD FOR PRODUCING ISOCYANATE | Asahi Kasei Kabushiki Kaisha (JP) | 2021-06-23 | — | — | EP | disclosed |
| EP-2980066-B1 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND (JP) | 2021-04-21 | — | — | EP | disclosed |
| US-20200225581-A1 | PHOTOSENSITIVE RESIN COMPOSITION, OPTICAL FILM, AND METHOD OF PRODUCING OPTICAL FILM | ECHEM SOLUTIONS CORP. (TW) | 2020-07-16 | — | — | US | disclosed |
| US-4219661-A | FROM THE NITRO COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1980-08-26 | — | — | US | disclosed |
| EP-0014406-A1 | Process for the separation of selenium, selenium compounds, sulfur and/or sulfur compounds from urethanes containing these elements and/or compounds | BAYER AG (DE) | 1980-08-20 | — | — | EP | disclosed |
| EP-0014406-A1 | Process for the separation of selenium, selenium compounds, sulfur and/or sulfur compounds from urethanes containing these elements and/or compounds | BAYER AG (DE) | 1980-08-20 | — | — | EP | disclosed |
| US-4081472-A | CATALYTIC, FROM A CARBAMATE | MITSUI TOATSU CHEMICALS INC. (JA) | 1978-03-28 | — | — | US | disclosed |
| US-3993685-A | Process for the production of urethanes | ATLANTIC RICHFIELD COMPANY (US) | 1976-11-23 | — | — | US | disclosed |
| US-3962302-A | Production of isocyanates from esters of carbamic acids (urethanes) | ATLANTIC RICHFIELD COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231495-A1 | METAL CARBAMATES FORMED FROM TOLYLENEDIAMINES | CHRM1, CARM1, TCP1 | NLRP3 4276/4885ALDH1A1 1601/4885LMNA 4197/4885 |
| US-20110004012-A1 | METAL CARBAMATES FORMED FROM TOLYLENEDIAMINES | CHRM1, CARM1, TCP1 | NLRP3 4276/4885ALDH1A1 1601/4885LMNA 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.